chr11-2929039-T-C

Variant summary

Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong

The NM_003311.4(PHLDA2):ā€‹c.326A>Gā€‹(p.Asp109Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000276 in 1,448,310 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā˜…).

Frequency

Genomes: not found (cov: 33)
Exomes š‘“: 0.0000028 ( 0 hom. )

Consequence

PHLDA2
NM_003311.4 missense

Scores

2
16

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: -0.391
Variant links:
Genes affected
PHLDA2 (HGNC:12385): (pleckstrin homology like domain family A member 2) This gene is located in a cluster of imprinted genes on chromosome 11p15.5, which is considered to be an important tumor suppressor gene region. Alterations in this region may be associated with the Beckwith-Wiedemann syndrome, Wilms tumor, rhabdomyosarcoma, adrenocortical carcinoma, and lung, ovarian, and breast cancer. This gene has been shown to be imprinted, with preferential expression from the maternal allele in placenta and liver. [provided by RefSeq, Oct 2010]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_benign. Variant got -2 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.04546714).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
PHLDA2NM_003311.4 linkuse as main transcriptc.326A>G p.Asp109Gly missense_variant 1/2 ENST00000314222.5 NP_003302.1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
PHLDA2ENST00000314222.5 linkuse as main transcriptc.326A>G p.Asp109Gly missense_variant 1/21 NM_003311.4 ENSP00000319231 P1

Frequencies

GnomAD3 genomes
Cov.:
33
GnomAD3 exomes
AF:
0.00000871
AC:
2
AN:
229586
Hom.:
0
AF XY:
0.00
AC XY:
0
AN XY:
126372
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.000116
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.00000276
AC:
4
AN:
1448310
Hom.:
0
Cov.:
31
AF XY:
0.00
AC XY:
0
AN XY:
720626
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.0000766
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.00
Gnomad4 OTH exome
AF:
0.0000167
GnomAD4 genome
Cov.:
33
Bravo
AF:
0.00000756
ExAC
AF:
0.0000166
AC:
2

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsFeb 13, 2024The c.326A>G (p.D109G) alteration is located in exon 1 (coding exon 1) of the PHLDA2 gene. This alteration results from a A to G substitution at nucleotide position 326, causing the aspartic acid (D) at amino acid position 109 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.14
BayesDel_addAF
Benign
-0.30
T
BayesDel_noAF
Benign
-0.44
CADD
Benign
16
DANN
Benign
0.92
DEOGEN2
Benign
0.13
T;T
Eigen
Benign
-0.94
Eigen_PC
Benign
-0.91
FATHMM_MKL
Benign
0.17
N
M_CAP
Pathogenic
0.37
D
MetaRNN
Benign
0.045
T;T
MetaSVM
Benign
-0.95
T
MutationAssessor
Benign
0.85
L;L
MutationTaster
Benign
0.54
N
PrimateAI
Pathogenic
0.82
D
PROVEAN
Benign
-1.3
N;.
REVEL
Benign
0.12
Sift
Benign
0.46
T;.
Sift4G
Benign
0.39
T;.
Polyphen
0.0010
B;B
Vest4
0.073
MutPred
0.21
Gain of MoRF binding (P = 0.0587);Gain of MoRF binding (P = 0.0587);
MVP
0.41
MPC
1.1
ClinPred
0.033
T
GERP RS
-2.5
Varity_R
0.060
gMVP
0.66

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs756159463; hg19: chr11-2950269; API